When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BBLG - Bone Biologics receives HREC approval for a clinical trial to evaluate NB1 in Australia
Bone Biologics Corp
Bone Biologics (OTCQB:BBLG) has received Human Research Ethics Committee (HREC) approval, for the first center of a pilot clinical trial to evaluate NB1 (NELL-1/DBX) in 30 patients in Australia.
More news on: Bone Biologics Corporation, Healthcare stocks news,